Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Inventory: 2020-2025

Historic Inventory for Cellebrite DI (CLBT) over the last 4 years, with Sep 2025 value amounting to $8.6 million.

  • Cellebrite DI's Inventory fell 11.07% to $8.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.6 million, marking a year-over-year decrease of 11.07%. This contributed to the annual value of $8.9 million for FY2024, which is 10.07% down from last year.
  • Cellebrite DI's Inventory amounted to $8.6 million in Q3 2025, which was down 9.32% from $9.5 million recorded in Q2 2025.
  • Cellebrite DI's 5-year Inventory high stood at $11.4 million for Q1 2023, and its period low was $4.8 million during Q3 2021.
  • Over the past 3 years, Cellebrite DI's median Inventory value was $9.5 million (recorded in 2025), while the average stood at $9.7 million.
  • Its Inventory has fluctuated over the past 5 years, first spiked by 94.47% in 2022, then dropped by 18.83% in 2024.
  • Quarterly analysis of 5 years shows Cellebrite DI's Inventory stood at $6.5 million in 2021, then surged by 56.29% to $10.2 million in 2022, then declined by 2.32% to $9.9 million in 2023, then declined by 10.07% to $8.9 million in 2024, then fell by 11.07% to $8.6 million in 2025.
  • Its Inventory stands at $8.6 million for Q3 2025, versus $9.5 million for Q2 2025 and $9.0 million for Q1 2025.